Literature DB >> 9581553

Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites.

F Shen1, H Wang, X Zheng, M Ratnam.   

Abstract

In a previous study with inhibitors of N-glycosylation, it was proposed that core glycosylation of the folate receptor (FR) is required for the proper folding of the protein [Luhrs (1991) Blood 77, 1171-1180]. The human FR isoforms type alpha and type beta have three and two candidate sites for N-glycosylation respectively, only one of which is conserved. The significance of N-glycosylation at each of these loci in the expression and function of FR was examined by eliminating the sites both individually and in combination by introducing Asn-->Gln substitutions. Translation experiments in vitro showed that the mutations did not alter the synthetic rates of the polypeptides. The recombinant proteins were expressed in human 293 fibroblasts. Treatment with N-glycanase and analysis by Western blotting of the wild-type and mutant proteins revealed that all of the candidate sites in both FR-alpha and FR-beta are glycosylated. When all of the N-glycosylation sites were abolished, 2% and 8% of FR-alpha and FR-beta respectively were expressed on the cell surface compared with the corresponding wild-type proteins; the residual FR polypeptides in the cell lysates were unable to bind [3H]folic acid. In both the proteins, the inclusion of each additional N-glycosylation site partly contributed to restoration of cell surface [3H]folic acid binding and receptor-mediated folate transport. Further, in FR-beta the introduction of an additional unnatural site of N-glycosylation resulted in the enhancement of the expression of the cell surface receptor compared with the wild-type protein. The results indicate that the total mass of N-glycosylation, not a specific locus of the modification, is critical for the efficient folding and optimal expression of functional FR-alpha and FR-beta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9581553      PMCID: PMC1218854          DOI: 10.1042/bj3270759

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

Authors:  C P Leamon; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.

Authors:  S W Lacey; J M Sanders; K G Rothberg; R G Anderson; B A Kamen
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  The role of glycosylation in the biosynthesis and acquisition of ligand-binding activity of the folate-binding protein in cultured KB cells.

Authors:  C A Luhrs
Journal:  Blood       Date:  1991-03-15       Impact factor: 22.113

4.  Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA.

Authors:  M Ratnam; H Marquardt; J L Duhring; J H Freisheim
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

Review 5.  A common mechanism for posttranslational activation of plasma membrane receptors?

Authors:  T S Olson; M D Lane
Journal:  FASEB J       Date:  1989-03       Impact factor: 5.191

6.  Expression of biologically active human corticosteroid binding globulin by insect cells: acquisition of function requires glycosylation and transport.

Authors:  J Ghose-Dastidar; J B Ross; R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

7.  Synthesis of epidermal growth factor receptor in human A431 cells. Glycosylation-dependent acquisition of ligand binding activity occurs post-translationally in the endoplasmic reticulum.

Authors:  L J Slieker; T M Martensen; M D Lane
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

8.  Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells.

Authors:  P C Elwood
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

9.  Constitutive apical secretion of an 80-kD sulfated glycoprotein complex in the polarized epithelial Madin-Darby canine kidney cell line.

Authors:  J Urban; K Parczyk; A Leutz; M Kayne; C Kondor-Koch
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

10.  The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway.

Authors:  K G Rothberg; Y S Ying; J F Kolhouse; B A Kamen; R G Anderson
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

View more
  9 in total

Review 1.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

2.  IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.

Authors:  Eric D Frontera; Rafa M Khansa; Dana L Schalk; Lauren E Leakan; Tracey J Guerin-Edbauer; Manohar Ratnam; David H Gorski; Cecilia L Speyer
Journal:  Breast Cancer Res Treat       Date:  2018-08-28       Impact factor: 4.872

3.  All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells.

Authors:  Ying Xu; Tianyou Wang; Ruihong Tang; Suoqin Tang
Journal:  Tumour Biol       Date:  2010-07-15

4.  Cancer chemotherapy: targeting folic acid synthesis.

Authors:  Nicole Hagner; Markus Joerger
Journal:  Cancer Manag Res       Date:  2010-11-19       Impact factor: 3.989

5.  A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity.

Authors:  Yang Feng; Jiayin Shen; Emily D Streaker; Michael Lockwood; Zhongyu Zhu; Philip S Low; Dimiter S Dimitrov
Journal:  Arthritis Res Ther       Date:  2011-04-08       Impact factor: 5.156

6.  Characterization of the human folate receptor alpha via novel antibody-based probes.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Earl Albone; Xin Cheng; Young Chul Park; Brian E Tomkowicz; Yoshitomo Hamuro; Thomas O Kohl; Tracy M Forsyth; Robert Smale; Yao-Shi Fu; Nicholas C Nicolaides
Journal:  Oncotarget       Date:  2011-12

Review 7.  Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review.

Authors:  Claudia Marchetti; Innocenza Palaia; Margherita Giorgini; Caterina De Medici; Roberta Iadarola; Laura Vertechy; Lavinia Domenici; Violante Di Donato; Federica Tomao; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Onco Targets Ther       Date:  2014-07-10       Impact factor: 4.147

8.  Growing Mouse Oocytes Transiently Activate Folate Transport via Folate Receptors As They Approach Full Size.

Authors:  Megan Meredith; Allison H MacNeil; Jacquetta M Trasler; Jay M Baltz
Journal:  Biol Reprod       Date:  2016-04-27       Impact factor: 4.285

9.  Leukemia-specific delivery of mutant NOTCH1 targeted therapy.

Authors:  Giovanni Roti; Jun Qi; Samuel Kitara; Marta Sanchez-Martin; Amy Saur Conway; Anthony C Varca; Angela Su; Lei Wu; Andrew L Kung; Adolfo A Ferrando; James E Bradner; Kimberly Stegmaier
Journal:  J Exp Med       Date:  2017-11-20       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.